Bovine Mastitis Market Share

  • Report ID: 4647
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Bovine Mastitis Market Share

North American Market Forecast   

The North American bovine mastitis market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the massively increasing prevalence of bovine mastitis in cattle, and the significantly expanding dairy industry in the region. For instance, in 2022, the number of dairy farm businesses in the United States has increased by approximately 34,950 farms. Further, the presence of major key players who are providing a wide range of treatment of this disease, along with a surge in animal healthcare infrastructure which is paving the way to make the farmers more aware for animal health, are also anticipated to contribute to the market growth in the region. In addition, rising investment in research and development in the effective treatment of mastitis is another sign which is estimated to drive the market growth further throughout the forecast period in the region.

APAC Market Statistics

The Asia Pacific bovine mastitis market is anticipated to display the fastest market growth by the end of 2036. The growth of the market can be attributed to the large number of cattle in the region, coupled with the rising cases of mastitis disease in cattle. Additionally, the surging count of dairy farms in this region is another key factor that is fueling the growth of the market during the projected time frame.

Research Nester
Global-Bovine-Mastitis-Market-share-image
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4647
  • Published Date: Jul 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of bovine mastitis is estimated at USD 2.29 Billion.

The bovine mastitis market size was over USD 2.15 Billion in 2023 and is anticipated to cross USD 5.43 Billion by the end of 2036, growing at more than 7.4% CAGR during the forecast period i.e., between 2024-2036. Enormous surge in dairy production across the globe, worldwide rise in the number of farm cattle, and globally escalating consumption of milk are some major factors driving the growth of the market.

North America is poised to hold largest industry share by 2036, attributed to massively increasing prevalence of bovine mastitis in cattle, and the significantly expanding dairy industry in the region.

Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Ceva Santé Animale, Nimrod Veterinary Products Ltd, Bayer AG, ImmuCell Corporation, West Way Health, Neogen Corporation, Forte Healthcare Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample